0 NASDAQ Companies - October 19, 2020Atossa Therapeutics Completes Enrollment of Phase 1 Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVIDBay Street NewsRead More
0 NASDAQ Companies - October 19, 2020Atossa Therapeutics Completes Enrollment of Phase 1 Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVIDBay Street NewsRead More
0 NASDAQ Companies - October 19, 2020Atossa Therapeutics Completes Enrollment of Phase 1 Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVIDBay Street NewsRead More
0 NASDAQ Companies - October 19, 2020Atossa Therapeutics Completes Enrollment of Phase 1 Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVIDBay Street NewsRead More
0 NASDAQ Companies - October 19, 2020Atossa Therapeutics Completes Enrollment of Phase 1 Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVIDBay Street NewsRead More
0 NASDAQ Companies - October 19, 2020ClearOne Announces New BMA 360 Beamforming Microphone Array Ceiling Tile – Setting Unrivaled Audio Performance Standard in the IndustryBay Street NewsRead More
0 NASDAQ Companies - October 19, 2020ClearOne Announces New BMA 360 Beamforming Microphone Array Ceiling Tile – Setting Unrivaled Audio Performance Standard in the IndustryBay Street NewsRead More
0 NASDAQ Companies - October 19, 2020ClearOne Announces New BMA 360 Beamforming Microphone Array Ceiling Tile – Setting Unrivaled Audio Performance Standard in the IndustryBay Street NewsRead More
0 NASDAQ Companies - October 19, 2020ClearOne Announces New BMA 360 Beamforming Microphone Array Ceiling Tile – Setting Unrivaled Audio Performance Standard in the IndustryBay Street NewsRead More
0 NASDAQ Companies - October 19, 2020ClearOne Announces New BMA 360 Beamforming Microphone Array Ceiling Tile – Setting Unrivaled Audio Performance Standard in the IndustryBay Street NewsRead More
